New EU Project Designed to Link Diagnosis and Treatment of Diseases over the Long Term An international team from four EU countries plans to use an innovative concept to improve the use of companion diagnostics in disease and develop new approaches to therapy in the long term. [Johannes Gutenberg-Universität Mainz] Press Release New Agreement to Open the Door to Next Generation Cell Therapies A new collaboration agreement has been announced by Macquarie University and clinical-stage regenerative medicine company Regeneus Ltd., to commercialize a breakthrough cell selection technology that for the first time allows high potency secreting stem cells to be identified and selected for the manufacture of next generation cell therapies. [Regeneus Ltd.] Press Release CPRIT Awards Faculty $19.6 Million for Research in Cervical, Breast, Lung, Colon, and Pediatric Cancers, and Cancer Biology The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern Medical Center researchers more than $19.6 million in research grants to improve preventive, diagnostic, and therapeutic services relating to cervical, breast, lung, colon, and pediatric cancers, as well as to improve scientific understanding of cancer biology. [UT Southwestern Medical Center] Press Release MassGeneral Hospital for Children Receives Grant to Pursue Novel Antibacterial Strategy MassGeneral Hospital for Children has been named a Grand Challenges Explorations winner through an initiative funded by the Bill & Melinda Gates Foundation. Researchers will pursue an innovative global health and development research project, titled “Disarming Type III Secretion System of Enteric Pathogens.” [MassGeneral Hospital (EurekAlert!)] Press Release Pembrolizumab in Advanced Melanoma: Added Benefit for Certain Patients The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether pembrolizumab offers an added benefit over the appropriate comparator therapy. According to the findings, an added benefit can be derived for different patient groups. [German Institute for Quality and Efficiency in Health Care] Press Release New Patent Paves Way for Breast Cancer Prevention George Mason University researchers have patented a new breast cancer treatment that uses a common malaria drug to stop cancer in its beginning stages. Chloroquine, a drug commonly given to prevent or treat malaria, targets ductal carcinoma in situ, the most common type of pre-invasive breast cancer. [George Mason University] Press Release FDA Approves Portrazza to Treat Advanced Squamous Non-Small Cell Lung Cancer The U.S. Food and Drug Administration approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced squamous non-small cell lung cancer who have not previously received medication specifically for treating their advanced lung cancer. [U.S. Food and Drug Administration] Press Release Adaptimmune Initiates Phase I/II Trial Evaluating Its Affinity Enhanced T-Cell Therapy Targeting Adaptimmune Therapeutics plc announced that it has initiated a study of its affinity enhanced T-cell therapy targeting the NY-ESO-1 cancer antigen in patients with Stage IIIb or Stage IV non-small cell lung cancer. [Adaptimmune Therapeutics plc] Press Release |